8 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more
Laurent Fischer
Inari
3 followers
Arcutis Biotherapeutics
2 followers
Mission Bio
4 followers
ALS Therapy Development Institute
3 followers
CHDI Foundation
5 followers
Affinia Therapeutics
1 follower
Thermo Fisher Scientific
174 followers
Genentech
159 followers
Gilead Sciences
133 followers
Regeneron
101 followers
BioMarin Pharmaceutical
36 followers
Explore companies